Phenamil methanesulfonate

Phenamil methanesulfonate 是 Amiloride (MS-G26615) 的类似物,一种更有效且不可逆的上皮钠通道 (ENaC) 阻滞剂(IC50 为 400 nM),同时也是 TRPP3 的竞争性抑制剂(在 Ca2+ 摄取实验中抑制 TRPP3 介导的 Ca2+ 转运的 IC50 为 140 nM),还是一种通过强烈激活 BMP 信号通路来促进骨修复的小分子,并用于囊性纤维化肺疾病的相关研究。
产品编号: MS-S91032 纯度: 98.1% CAS No.: 1161-94-0 分子式: C13H16ClN7O4S 分子量: 401.83
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价

产品描述

Phenamil methanesulfonate 是 Amiloride (MS-G26615) 的类似物,一种更有效且不可逆的上皮钠通道 (ENaC) 阻滞剂(IC50 为 400 nM),同时也是 TRPP3 的竞争性抑制剂(在 Ca2+ 摄取实验中抑制 TRPP3 介导的 Ca2+ 转运的 IC50 为 140 nM),还是一种通过强烈激活 BMP 信号通路来促进骨修复的小分子,并用于囊性纤维化肺疾病的相关研究。

生物实验数据

生物活性 Phenamil methanesulfonate is an analog of Amiloride (MS-G26615), a more potent and irreversible epithelial sodium channel (ENaC) blocker with an IC50 of 400 nM, and also a competitive inhibitor of TRPP3 with an IC50 of 140 nM for inhibiting TRPP3-mediated Ca2+ transport in Ca2+ uptake assays; it is a small molecule that promotes bone repair by strongly activating the BMP signaling pathway and is used in research related to cystic fibrosis lung disease.
IC50 & Target ENaC:400 nM
体外研究
(In Vitro)

TRPP3, a member of the transient receptor potential (TRP) superfamily of cation channels, is a Ca2+-activated channel permeable to Ca2+, Na+, and K+. TRPP3 is implicated in regulation of pH-sensitive action potential in spinal cord neurons.
Phenamil methanesulfonate (1 μM) decreases 45Ca2+ uptake in a radiotracer uptake assay. It inhibits TRPP3-mediated Ca2+ transport with an IC50 value of 0.28 μM in oocytes expressing TRPP3 or H2O-injected oocytes.
Phenamil methanesulfonate is a more potent ENaC blocker than Amiloride, it inhibits the epithelial sodium channel (ENaC) with an IC50 of 400 nM (Amiloride=776 nM).
Phenamil methanesulfonate inhibits basal short-circuit currents with IC50 values of 75 and 116 nM, respectively in both human and ovine bronchial epithelia cells.
Phenamil methanesulfonate (0-20 μM; 14 days) elevates adipogenic gene expression, PPARγ, Fabp4, and lipoprotein lipase expression in a concentration-dependent manner,and regulates adipogenesis in C3H10T1/2 cells.
Phenamil methanesulfonate (0-20 μM; 7 or 14 days) modulates MC3T3-E1 osteoblastic differentiation, it increases Alkaline phosphatase (ALP) activity in MC3T3-E1 cells in a concentration-dependent manner.

RT-PCR

Cell Line: C3H10T1/2 cells
Concentration: 0 μM and 20 μM
Incubation Time: 14 days
Result: Increased PPARγ, Fabp4, and lipoprotein lipase (LPL) mRNA expression.
体内研究
(In Vivo)

Phenamil methanesulfonate (subcutaneous injection; 15 or 30 mg/kg; 21 days; infusion rate of 1 ml/h) reduces chronic-hypoxia-induced pulmonary artery hypertension (PAH). Additionally, the mRNA level of SMA, SM22, Id3, and Trb3 from the lung sample are also decreased by Phenamil under hypoxia or normoxia in rats. However, phenamil has little effect on pulmonary vasculature under physiological conditions.

Animal Model: Male Sprague-Dawley rats
Dosage: 15 or 30 mg/kg
Administration: Subcutaneous injection; 15 or 30 mg/kg; 21 days; infusion rate of 1 ml/h
Result: Reduced hypoxia-induced pulmonary hypertension and vascular remodeling. 
性状 固体
颜色 Light yellow to yellow

化学信息

分子量 401.83
分子式 C13H16ClN7O4S
CAS No. 1161-94-0

储存&溶解度

储存方式

-20°C, stored under nitrogen

*In solvent: -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 25 mg/mL (62.22 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.4886 mL12.4431 mL24.8861 mL62.2154 mL
5 mM0.4977 mL2.4886 mL4.9772 mL12.4431 mL
10 mM0.2489 mL1.2443 mL2.4886 mL6.2215 mL
15 mM0.1659 mL0.8295 mL1.6591 mL4.1477 mL
20 mM0.1244 mL0.6222 mL1.2443 mL3.1108 mL
25 mM0.0995 mL0.4977 mL0.9954 mL2.4886 mL
30 mM0.0830 mL0.4148 mL0.8295 mL2.0738 mL
40 mM0.0622 mL0.3111 mL0.6222 mL1.5554 mL
50 mM0.0498 mL0.2489 mL0.4977 mL1.2443 mL
60 mM0.0415 mL0.2074 mL0.4148 mL1.0369 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础